Synbiotic Health was formed in 2018 by four academic researchers at the University of Nebraska with a combined century of experience in microbiome research, Dr. Bob Hutkins, Dr. Andy Benson, Dr. Jens Walter, and Dr. Tom Burkey. In 2019, Tim Brummels became the Chief Executive Officer. Synbiotic Health’s flagship probiotic strain, iVS-1®, was discovered in the UNL research labs and was exclusively licensed to Synbiotic Health. The founders of Synbiotic Health are committed to developing critical probiotic cultures that will improve quality of life, healthy aging and human well-being.